Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05210673 |
Other study ID # |
ERAS in radical cystectomy |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 1, 2019 |
Est. completion date |
September 30, 2021 |
Study information
Verified date |
January 2022 |
Source |
Menoufia University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the
postoperative hospital stay after radical cystectomy is reduced, and also postoperative
complications are decreased.
Description:
Radical cystectomy (RC) is believed to be associated with high morbidity and prolonged length
of hospital stay even with advances in perioperative medical care. Enhanced Recovery After
Surgery (ERAS) pathways are multidisciplinary, multimodal evidence-based approaches to
perioperative protocol by which patients are treated. The most important aims of this
multimodal approach are modifying as many of the factors contributing to the morbidity of RC
as possible, the improvement of patients' preoperative status, and the perioperative
maintenance of homeostasis by minimizing stress response and inflammation to improve patient
outcomes and decrease the length of inpatient hospital stay. The investigators hypothesize
that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay
after radical cystectomy is reduced, and also postoperative complications are decreased.